Sulfo-Cyanine5 maleimide
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 13380 | 1 mg | $110.00 | in stock | |
| 23380 | 5 mg | $290.00 | in stock | |
| 43380 | 25 mg |
$690.00
|
in stock | |
| 53380 | 50 mg |
$1270.00
|
in stock | |
| 63380 | 100 mg |
$1990.00
|
in stock |
A water soluble, hydrophilic sulfo-Cyanine5 maleimide (Cy5® maleimide analog). We recommend this product for protein labeling, including labeling of antibodies as a perfect replacement for Cy5® maleimide. Labeled proteins can be easily separated from unreacted dye by gel filtration, spin column purification, dialysis, electrophoresis or chromatography.
An analog without sulfo groups, Cyanine5 maleimide, is also available.
Sulfo-Cyanine5 absorbance and emission spectra
Recommended protocol
Customers also purchased with this product
DMF (dimethylformamide), labeling grade
Dry high purity amine free solvent for NHS ester labeling.BDP 581/591 maleimide
Thiol reactive maleimide derivative of BDP 581/591 dye. The fluorophore is useful for a variety of application, including fluorescence polarization assays, and microscopy.FAM NHS ester, 6-isomer
Activated N-hydroxysuccinimide ester of fluorescein (FAM), pure 6-isomer.General properties
| Appearance: | dark blue powder |
| Molecular weight: | 803.00 |
| CAS number: | 2242791-82-6 (potassium salt); 2130955-10-9 (inner salt); 2242791-81-5 (inner salt); 2301999-22-2 (sodium salt) |
| Molecular formula: | C38H43KN4O9S2 |
| Solubility: | soluble in water, DMSO, DMF |
| Quality control: | NMR 1H, HPLC-MS (95+%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation maximum, nm: | 646 |
| ε, L⋅mol−1⋅cm−1: | 271000 |
| Emission maximum, nm: | 662 |
| Fluorescence quantum yield: | 0.28 |
| CF260: | 0.04 |
| CF280: | 0.04 |
Product citations
- Cioloboc, D.; Kurtz, D.M. Targeted cancer cell delivery of arsenate as a reductively activated prodrug. Journal of Biological Inorganic Chemistry, in press. doi: 10.1007/s00775-020-01774-3
- Baranova, N.; Radler, P.; Hernández-Rocamora, V.M.; Alfonso, C.; López-Pelegrin, M.; Rivas, G.; Vollmer, W.; Loose, M. Diffusion and capture permits dynamic coupling between treadmilling FtsZ filaments and cell division proteins. Nature Microbiology, 2020, 5, 407–417. doi: 10.1038/s41564-019-0657-5
- Ji, W.; Smith, P.N.; Koepsel, R.R.; Andersen, J.D.; Baker, S.L.; Zhang, L.; Carmali, S.; Myerson, J.W.; Muzykantov, V.; Russell, A.J. Erythrocytes as Carriers of Immunoglobulin-Based Therapeutics. Acta Biomaterialia, 2020, 101, 422–435. doi: 10.1016/j.actbio.2019.10.027
- Cliff, L.; Chadda, R.; Robertson, J.L. Occupancy distributions of membrane proteins in heterogeneous liposome populations. BBA Biomembranes, 2020, 1862(1), 183033. doi: 10.1016/j.bbamem.2019.183033
Cy® is a trademark of GE Healthcare.
The count of items is incorrect.
Your cart is empty
$ 
